The association between VDR polymorphisms and renal cell carcinoma susceptibility: A meta-analysis

Tumor Biology

Volumn 35, Issue 6, 2014, Pages 6065-6072

  Meng, Fandong ^a   Ma, Ping ^a   Sui, Chengguang ^a   Tian, Xin ^a   Li, Yan ^a   Fu, Liye ^a   Jiang, Tao ^a   Wang, Yang ^a   Jiang, Youhong ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Meta analysis; Polymorphism; Renal cell carcinoma; Vitamin D receptor

Indexed keywords

VITAMIN D RECEPTOR;

ARTICLE; CANCER SUSCEPTIBILITY; DNA POLYMORPHISM; ETHNICITY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC MODEL; GENOTYPING TECHNIQUE; HUMAN; INFORMATION RETRIEVAL; KIDNEY CARCINOMA; MEDLINE; META ANALYSIS (TOPIC); PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

CARCINOMA, RENAL CELL; GENETIC PREDISPOSITION TO DISEASE; HUMANS; KIDNEY NEOPLASMS; POLYMORPHISM, GENETIC; PUBLICATION BIAS; RECEPTORS, CALCITRIOL; RISK;

EID: 84904749464     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-014-1803-6     Document Type: Article

References (26)

1. Chow WH, Devesa SS, Warren JL, Fraumeni JF. Rising incidence of renal cell cancer in the United States. JAMA. 1999;281:1628-31. (Pubitemid 29211773)
2. Mathew A, Devesa SS, Fraumeni Jr JF, Chow WH. Global increases in kidney cancer incidence, 1973-1992. Eur J Cancer Prev. 2002;11:171-8. (Pubitemid 34478435)
3. Raimondi S, Johansson H, Maisonneuve P, Gandini S. Review and meta-analysis on vitamin D receptor polymorphisms and cancer risk. Carcinogenesis. 2009;30:1170-80.
4. Deeb KK, Trump DL, Johnson CS. Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer. 2007;7:684-700. (Pubitemid 47327412)
5. Plum LA, DeLuca HF. Vitamin D, disease and therapeutic opportunities. Nat Rev Drug Discov. 2010;9:941-55.
6. Southard EB, Roff A, Fortugno T, Richie Jr JP, Kaag M, Chinchilli VM, et al. Lead, calcium uptake, and related genetic variants in association with renal cell carcinoma risk in a cohort of male Finnish smokers. Cancer Epidemiol Biomarkers Prev. 2012;21:191-201.
7. Arjumand W, Ahmad ST, Seth A, Saini AK, Sultana S. Vitamin D receptor FokI and BsmI gene polymorphism and its association with grade and stage of renal cell carcinoma in North Indian population. Tumour Biol. 2012;33:23-31.
8. Karami S, Brennan P, Hung RJ, Boffetta P, Toro J, Wilson RT, et al. Vitamin D receptor polymorphisms and renal cancer risk in Central and Eastern Europe. J Toxicol Environ Health A. 2008;71:367-72. (Pubitemid 351206458)
9. Ikuyama T, Hamasaki T, Inatomi H, Katoh T, Muratani T, Matsumoto T. Association of vitamin D receptor gene polymorphism with renal cell carcinoma in Japanese. Endocr J. 2002;49:433-8. (Pubitemid 34988234)
10. Obara W, Suzuki Y, Kato K, Tanji S, Konda R, Fujioka T. Vitamin D receptor gene polymorphisms are associated with increased risk and progression of renal cell carcinoma in a Japanese population. Int J Urol. 2007;14:483-7. (Pubitemid 46985542)
11. Cochran WG. The comparison of percentages in matched samples. Biometrika. 1950;37:256-66.
12. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-60. (Pubitemid 37088507)
13. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719-48.
14. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-88. (Pubitemid 17189972)
15. Tobias A. Assessing the influence of a single study in the meta-analysis estimate. Stata Tech Bull. 1999;8:15-7.
16. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test.BMJ. 1997;315:629-34. (Pubitemid 27387172)
17. Stuck AE, Rubenstein LZ, Wieland D. Bias in meta-analysis detected by a simple, graphical test. Asymmetry detected in funnel plot was probably due to true heterogeneity. BMJ. 1998;316:469. Author reply 470-1.
18. Uitterlinden AG, Fang Y, Van Meurs JB, Pols HA, Van Leeuwen JP. Genetics and biology of vitamin D receptor polymorphisms. Gene. 2004;338:143-56. (Pubitemid 39094759)
19. Trabert B, Malone KE, Daling JR, Doody DR, Bernstein L, Ursin G, et al. Vitamin D receptor polymorphisms and breast cancer risk in a large population-based case-control study of Caucasian and African-American women. Breast Cancer Res. 2007;9:R84.
20. Cheteri MB, Stanford JL, Friedrichsen DM, Peters MA, Iwasaki L, Langlois MC, et al. Vitamin D receptor gene polymorphisms and prostate cancer risk. Prostate. 2004;59:409-18. (Pubitemid 38661808)
21. Tworoger SS, Gates MA, Lee IM, Buring JE, Titus-Ernstoff L, Cramer D, et al. Polymorphisms in the vitamin D receptor and risk of ovarian cancer in four studies. Cancer Res. 2009;69:1885-91.
22. Hubner RA, Muir KR, Liu JF, Logan RF, Grainge MJ, Houlston RS, et al. Dairy products, polymorphisms in the vitamin D receptor gene and colorectal adenoma recurrence. Int J Cancer. 2008;123:586-93. (Pubitemid 351898416)
23. Arai H, Miyamoto KI, Taketani Y, Yamamoto H, Iemori Y, Morita K, et al. A vitamin D receptor gene polymorphism in the translation initiation codon: effect on protein activity and relation to bone mineral density in Japanesewomen. J Bone Miner Res. 1997;12:915-21. (Pubitemid 27225001)
24. Jurutka PW, Remus LS, Whitfield GK, Thompson PD, Hsieh JC, Zitzer H, et al. The polymorphic N terminus in human vitamin D receptor isoforms influences transcriptional activity by modulating interaction with transcription factor IIB. Mol Endocrinol. 2000;14:401-20. (Pubitemid 32260532)
25. Jurutka PW, Whitfield GK, Hsieh JC, Thompson PD, Haussler CA, Haussler MR. Molecular nature of vitamin D receptor and its role in regulation of gene expression. Rev Endocrin Metab Disord. 2001;2:203-16. (Pubitemid 33635523)
26. Motzer RJ, Bander NH, Nanus DM. Renal cell carcinoma. N Engl J Med. 1996;335:865-75.